International Journal of Clinical Pharmacy

Article	Citations
ESCP International Workshop: Pharmacotherapy challenges in the developing years: from conception to adolescence 24–25 April 2024, Bratislava, Slovakia	69
Comment on: “whether temporal discounting is domain‑specific between health outcomes and money—a systematic review and meta‑analysis”	57
Implementation status of safety measures to prevent errors with non-oncologic methotrexate: surveys in community and hospital pharmacies	41
Characterising pharmacists’ interventions in chronic non-cancer pain care: a scoping review	40
Variation in vancomycin dosing and therapeutic drug monitoring practices in neonatal intensive care units	35
Parents’ perspectives towards paediatric confectionary masked medications: a qualitative study	35
A systematic review of quantitative studies exploring staff views on antipsychotic use in residents with dementia in care homes	30
A 5-year trend in the use of sodium-glucose co-transporter 2 inhibitors and other oral antidiabetic drugs in a Middle Eastern country	30
Medication regimen complexity index and rehabilitation outcomes in post-acute hip fracture patients study: a retrospective study	29
Efficacy and safety of metformin compared to insulin in gestational diabetes: a systematic review and meta-analysis of Chinese randomized controlled trials	28
Non-cardiovascular medication and readmission for heart failure: an observational cohort study	28
Descriptive analysis of reported adverse events associated with anti-obesity medications using FDA Adverse Event Reporting System (FAERS) databases 2013–2020	28
Development and evaluation of an assessment of the age-appropriateness/inappropriateness of formulations used in children	27
Attitudes of non-participating general practitioners and community pharmacists towards interprofessional medication management in primary care: an interview study	27
Bacillus coagulans TBC169 probiotics for intestinal function recovery after gynecological open surgery: a randomized, double-blind, placebo-controlled trial	25
Response to comment on 'Perioperative esketamine combined with butorphanol versus butorphanol alone for pain management following video-assisted lobectomy: a randomized controlled trial'	25
Cost-effectiveness analysis of fruquintinib in Chinese patients with refractory metastatic colorectal cancer	24
Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study	24
Global trends in pharmacovigilance-related events: a 30-year analysis from the 2019 global burden of disease study	23
Impact of intra-patient variability of tacrolimus on allograft function and CD4 + /CD8 + ratio in kidney transplant recipients: a retrospective single-center study	22
Clinical impact of an individualised clinical pharmacy programme into the memory care pathway of older people: an observational study	21
Anti‑CGRP monoclonal antibodies in resistant migraine: preliminary real-world effectiveness and clinical predictors of response at two years	21
Identification of novel signal of proton pump inhibitor-associated drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis	21
Comparing patient reported and medical record data of adverse drug reactions to anti-seizure drugs	21
Ethical conflicts in patient care situations of community pharmacists: a cross-sectional online survey	21

Real-world data of atezolizumab in patients with previously treated locally advanced or metastatic urothelial bladder cancer	21
Fluoropyridmidine use and hypertriglyceridemia among Japanese patients: analysis of adverse event database	20
Reliability and validity testing of the medicines related - consultation assessment tool for assessing pharmacists’ consultations	20
Effects of children’s criteria for identifying potentially inappropriate prescribing on prescription review by pharmacists: a before-after study	19
Correlation between the prognostic nutritional index and outcomes in older patients aged ≥ 60 years with chronic heart failure	18
Conversational agents for pharmaceutical use: insights from the eCCo database	18
Environmental scan of current strategies to decrease sedative-hypnotic drug use and promote sleep in hospital patients	17
Sedative co-medication patterns across frailty states in people with HIV: a network-based study	17
Medication errors in emergency departments: a systematic review and meta-analysis of prevalence and severity	17
Discrepancies in patients' medication lists from pharmacies in Sweden: an interview study before the implementation of the Swedish National Medication List	16
Correction to: 49th ESCP virtual symposium on clinical pharmacy 19.10.2021–21.10.2021 Clinical pharmacy, working collaboratively in mental health care	16
Developing a machine learning model for predicting venlafaxine active moiety concentration: a retrospective study using real-world evidence	16
How to manage the dose of drugs in cancer patients with acute kidney injury, practical recommendations	16
The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta-analysis	16
Association of opioid fills with centers for disease control and prevention opioid guidelines and payer coverage policies: physician, insurance and geographic factors	15
Detection and management of pill swallowing difficulties: a community pharmacy-based observational study	15
Barriers to person-centered service design in pharmacy practice: examples, lessons, and potential solutions	14
Appropriateness of intravenous fluid prescriptions in hospitalised patients: a point prevalence study	14
Consumer views on the use of digital tools for reporting adverse drug reactions: a cross-sectional study	14
Comparison of various basal insulin dose adjustments for inpatients while unable to eat	14
Evaluation of osimertinib for advanced non-small cell lung cancer with leptomeningeal metastases: a cost-effectiveness and budget impact analysis	14
Critical care pharmacy service provision and workforce in adult extracorporeal membrane oxygenation centres: a multicentre cross-sectional survey	14
Translation and validation of the CLEO tool in Vietnamese to assess the significance of pharmacist interventions	14
Medication supply at hospital discharge via community pharmacy: a quality improvement study	13
Assessing safety concerns of interstitial lung disease associated with antibody-drug conjugates: a real-world pharmacovigilance evaluation of the FDA adverse event reporting system	13
Adherence to endocrine therapy in patients with hormone receptor-positive early-stage breast cancer: a retrospective study	13
A case–control study on the clinical characteristics of granisetron-related arrhythmias and the development of a predictive nomogram	13
Prolonged oxycodone use and potential risk factors in postoperative patients: a case control study	13
A machine learning model exploring the relationship between chronic medication and COVID-19 clinical outcomes	12
An umbrella review of the diagnostic value of next-generation sequencing in infectious diseases	12
Correction to: 50th ESCP Symposium on Clinical Pharmacy, Polypharmacy and ageing - highly individualized, interprofessional, person-centered care	12
Pharmacist-led deprescribing of cardiovascular and diabetes medication within a clinical medication review: the LeMON study (Less Medicines in Older Patients in the Netherlands), a cluster randomized	12
How to write a successful grant application: guidance provided by the European Society of Clinical Pharmacy	12
Novel opportunities for clinical pharmacy research: development of a machine learning model to identify medication related causes of delirium in different patient groups	12
Liver injury associated with endothelin receptor antagonists: a pharmacovigilance study based on FDA adverse event reporting system data	12
Cost-effectiveness of toripalimab plus chemotherapy for advanced esophageal squamous cell carcinoma	11
Risk factors for opioid toxicity requiring naloxone rescue in adults: a case-control study	11
Impact of a clinical pharmacist on medication safety in mental health Hospital-in-the-Home: a retrospective analysis	11
Potentially inappropriate prescribing in a falls clinic using the STOPP and START criteria	11
Cardiometabolic risk in people under 40 years with severe mental illness: reading between the guidelines	11
Prevalence and trends in polypharmacy and excessive polypharmacy: a retrospective national database analysis (2012–2021)	10
Comment on “Association of polypharmacy with clinical outcomes and healthcare utilization in older adults with cardiometabolic diseases: a retrospective cohort study”	10
Complementary and alternative medicine use in self-management of diabetes: A qualitative study of patient and user conversations in online forums	10
Valproic acid for agitation in the intensive care unit: an observational study of psychiatric consults	10
Application of a screening tool to understand the medication habits of patients with swallowing difficulty: a prospective observational study	10
Drivers of engagement in virtual communities of practice: a qualitative study of Australian pharmacists’ perceptions and experiences	10
Pharmacist-driven antimicrobial stewardship interventions in patients with COVID-19: a scoping review	10
What do emergency department pharmacist practitioners know and understand about patient safeguarding? A qualitative study	10
Embedding cultural competency and cultural humility in undergraduate pharmacist initial education and training: a qualitative exploration of pharmacy student perspectives	10
Cost-effectiveness of miglustat versus symptomatic therapy of Niemann–Pick disease type C	10

A quality improvement study on the effect of electronic transmission of a basic discharge medication report on medication discrepancies in patients discharged from the hospital	9
Classification of patient characteristics associated with reported adverse drug events to neuraminidase inhibitors: an applicability study of latent class analysis in pharmacovigilance	9
Opinions and experiences on the provision of care to people with mental illnesses: a qualitative study with Doctor of Pharmacy graduates after a rotation in psychiatry	9
Identification of factors for a successful implementation of medication reviews in community pharmacies: Using Positive Deviance in pharmaceutical care	9
Comment on “The efficacy of zuranolone versus placebo in postpartum depression and major depressive disorder: a systematic review and meta-analysis”	9
Prescribing at 95 years of age: cross-sectional findings from the Newcastle 85+ study	9
Anticholinergic burden and health-related quality of life among adult patients in a resource-limited setting: a cross-sectional study	9
Exploring the time required by pharmacists to prepare discharge medicine lists: a time-and-motion study	9
Evaluating an integrated clinical pharmacist model in a geriatric day hospital: a prospective single-centre observational study	9
Potential drug-drug interactions of immunosuppressants in kidney transplant recipients: comparison of drug interaction resources	9
Predicting delirium in older non-intensive care unit inpatients: development and validation of the DELIrium risK Tool (DELIKT)	9
Artificial intelligence in academic writing and clinical pharmacy education: consequences and opportunities	9
A cost–benefit analysis of hospital-wide medication reviews: a period prevalence study	9
Building an effective medicines optimisation model: a health system approach	9
A consolidated framework for implementation research (CFIR) guided exploration of key informant perspectives on establishing a pharmacist-led anticoagulation service in primary care: a qualitative stu	9
Factors associated with Turkish pharmacists’ intention to receive COVID-19 vaccine: an observational study	9
How patient-centredness takes place in pharmacy encounters: a critical common-sense interpretation of video-recorded meetings	9
Exploring the suitability of a ward-based clinical pharmacy activity collection tool for ambulatory care practice: a mixed-methods study	9
Economic evaluation of camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma in the United States and China	9
SGLT2 inhibitors associated pancreatitis: signal identification through disproportionality analysis of spontaneous reports and review of case reports	9
Cost-effectiveness of clobazam as an adjunctive treatment for refractory epilepsy in China	8
Addressing the second victim phenomenon among community pharmacists and its impact on clinical pharmacy practice: a consensus study	8
Impact of artificial intelligence on the academic performance and test anxiety of pharmacy students in objective structured clinical examination: a randomized controlled trial	8
Barriers and facilitators for the implementation of the CombiConsultation by general practitioners, pharmacists and practice nurses: a qualitative interview study	8
Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study	8
Real-world safety of maribavir: a retrospective study based on signal detection in the FDA adverse event reporting system	8
Communication issues between pharmacists and d/Deaf people: a qualitative study in Thailand	8
Association between sodium-glucose cotransporter 2 inhibitors and cancer: a systematic review and meta-analysis of randomized active-controlled trials	8
A randomised, crossover trial exploring the patient perspective and effectiveness of biosimilar adalimumab transition: IBD reference and biosimilar adalimumab cross over study (iBaSS)	8
Between what is and what could be: a survey of pharmacists’ practices, attitudes, and beliefs in the provision of mental health care	8
Preliminary feasibility assessment of a targeted, pharmacist-led intervention for older adults with polypharmacy: a mixed-methods study	8
Clinical Pharmacist and Clinical Nurse Specialist led medicine optimisation and medication adherence via eArly identifiCation advanCed gEriatric aSsesSment (ACCESS) tool in Senior Adult Oncology Progr	8
A real-world pharmacovigilance study of belzutifan in renal cell carcinoma and von Hippel-Lindau disease: insights from the FDA adverse event reporting system database	8
A retrospective cohort study of the effect of rapid versus delayed-result procalcitonin testing on antibiotic use at a community hospital	8
Assessing the cost-effectiveness of replacing antimetabolites with mTOR inhibitors in heart transplant immunosuppression in China: a network meta-analysis-based economic evaluation	8
Risk factors for potentially inappropriate medication use in older adults: a cohort study	8
Discrepancies among equations to estimate the glomerular filtration rate for drug dosing decision making in aged patients: a cross sectional study	7
Drug-related emergency department visits: external validation of an assessment tool in a general emergency department population	7
Pharmacist-led new medicine service: a real-world cohort study in the Netherlands on drug-related problems, satisfaction, and self-efficacy in cardiovascular patients transitioning to primary care	7
European Society of Clinical Pharmacy: ‘Implementing and scaling sustainable clinical pharmacy’	7
Economic cost-benefit analysis of person-centred medicines reviews by general practice pharmacists	7
Investigating the controversy surrounding statin therapy and Achilles tendinopathy using Mendelian randomization analysis	7
Polypharmacy and medication regimen complexity in transfusion-dependent thalassaemia patients: a cross- sectional study	7
A qualitative exploration of the enablers and barriers to the provision of outpatient clinics by hospital pharmacists	7
Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database	7
Patient and hospital staff perspectives on introducing pharmacist-led medication reviews at an orthopedic ward: a mixed methods pilot study	7
Antimicrobial utilization and resistance in Pseudomonas aeruginosa using segmented regression analysis: a comparative study between Serbia and eight European Countries	7
A qualitative evaluation of barriers and facilitators to a large-scale antithrombotic stewardship intervention in the United States Veterans Healthcare system	7
Development of a robust predictive model for neutropenia after esophageal cancer chemotherapy using GLMMLasso	7
Sex differences among users of NSAIDs and opioids during COVID-19 Pandemic	7
Correction: The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta‑analysis	7
Determining sensitivity and specificity of risk scores for QTc interval prolongation in hemato-oncology patients prescribed systemic antifungal therapy: a retrospective cross-sectional study	7
Medication changes and potentially inappropriate prescribing in older patients with significant polypharmacy	7
Population- and individual-level trajectories of opioid prescription patterns among adults with cerebral palsy: a retrospective cohort study	7
Implementation of pharmacist-led deprescribing in collaborative primary care settings	7
Sex differences in immune-related adverse events with immune checkpoint inhibitors: data mining of the FDA adverse event reporting system	7
Comparison of the incidence of nausea and vomiting between linezolid and vancomycin using claims database: a retrospective cohort study	7
Cost-effectiveness analysis of tislelizumab plus chemotherapy versus standard chemotherapy in first-line treatment for extensive-stage small cell lung cancer: perspectives from the United States and C	7
Publisher Correction to: Bacillus coagulans TBC169 probiotics for the recovery of intestinal function after gynecological laparoscopic surgery: a randomized, placebo-controlled trial	6
Abstracts of the 26th Annual Meeting of ESPACOMP, the International Society for Medication Adherence, Berlin, Germany, 17–19 November 2022	6
Levels of serum lipids predict responses to PD-L1 inhibitors as first-line treatment in small cell lung cancer: an observational study	6
Associated factors and safety of the rapidly achieving first therapeutic target of warfarin in hospitalized patients: a retrospective cohort study	6
Flight safety risk assessment of self-medication among fighter pilots: a cross-sectional study	6
Effectiveness of a structured pharmacist-delivered intervention for patients post-acute coronary syndromes on all-cause hospitalizations and cardiac-related hospital readmissions: a prospective quasi-	6
Optimising adherence to secondary prevention medications following acute coronary syndrome utilising telehealth cardiology pharmacist clinics: a matched cohort study	6
Remdesivir for COVID-19 and acute kidney injury: disproportionality analysis of data from the U.S. Food and Drug Administration Adverse Event Reporting System	6
ESCP Spring Workshop 2023: Advancing clinical pharmacy and care in diabetes and cardiovascular comorbidities—Antwerp, 20–21 April 2023	6
Feasibility of individualised patient modelling for continuous vancomycin infusions in outpatient antimicrobial therapy, a retrospective study	6
Delabeling of allergy to beta-lactam antibiotics in hospitalized patients: a prospective study evaluating cost savings	6
Correction: Development and validation of a Medication Adherence Universal Questionnaire: the MAUQ	6
Evaluating the impact of PD-1 inhibitor treatment on key health outcomes for cancer patients in China	6
“A little bit more looking…listening and feeling” A qualitative interview study exploring advanced clinical practice in primary care and community pharmacy	6
Influence of a ward-based pharmacist on the medication quality of geriatric inpatients: a before–after study	6
Short-term outcome of personalized theory-based pharmaceutical care service on the medication administration problems of family caregivers: a pre-post intervention study	6
Accuracy of best possible medication histories by pharmacy students: an observational study	6
Terms used to describe and define activities undertaken as a result of the medication review process: Do they require standardisation? A systematic review	6
Polypharmacy and medication regimen complexity in older patients with hemophilia or von willebrand disease: the M’HEMORRH-AGE study	6
Correction: Credentialed pharmacist-led home medicines reviews targeting treatable traits and their impact on health outcomes in people with chronic obstructive pulmonary disease: a pre- and post-inte	6
Author Correction: Assessing safety concerns of interstitial lung disease associated with antibody-drug conjugates: a real-world pharmacovigilance evaluation of the FDA adverse event reporting system	6
Co-designing psychosis simulated patient scenarios with mental health stakeholders for pharmacy curricula	6

Comparison of clinical effectiveness of conbercept and ranibizumab for treating retinopathy of prematurity: a meta-analysis	6
An assessment of the reporting of tapering methods in antidepressant discontinuation trials using the TIDieR checklist	6
Development, implementation and evaluation of the digital transformation of renal services in Wales: the journey from local to national	6
Scope, content and quality of clinical pharmacy practice guidelines: a systematic review	6
Provision of drug and alcohol services amidst COVID-19 pandemic: a qualitative evaluation on the experiences of service providers	6
Formal and informal venous thromboembolism risk assessment and impact on prescribing of thromboprophylaxis: a retrospective cohort study	5
Thank you from the Editor-in-Chief	5
Improving medication adherence in the community: a purposive umbrella review of effective patient-directed interventions that are readily implementable in the United Kingdom National Health Service	5
Developing a machine learning-based predictive model for the analgesic effectiveness of transdermal fentanyl in cancer patients: an interpretable approach	5
Correction to: Cost-effectiveness of check of medication appropriateness: methodological approach	5
Accuracy in patient-reported adverse drug reactions and their recognition: a mixed-methods study	5
Consensus on the criteria for patient prioritization in hospital clinical pharmacy services: a Delphi study	5
Characteristics of hospital pharmacist interventions and their clinical, economic and organizational impacts: a five-year observational study on the French National Observatory	5
Model-informed precision dosing of vancomycin in clinical practice: an intervention development study	5
Just a ‘romantic idea’? A theory-based interview study on medication review implementation with pharmacy owners	5
Community pharmacists’ acceptability of pharmacist-delivered depression screening for older adults: a qualitative study	5
Interventions to improve medicines optimisation in frail older patients in secondary and acute care settings: a systematic review of randomised controlled trials and non-randomised studies	5
Glucagon-like peptide 1 receptor agonists and the potential risk of pancreatic carcinoma: a pharmacovigilance study using the FDA Adverse Event Reporting System and literature visualization analysis	5
Intentions of hospital pharmacists to use digital technology in their daily practice: a cross-sectional survey using the Theory of Planned Behaviour	5
A qualitative exploration of the impact of a hospital electronic prescribing and medicines administration (HEPMA) protocol on junior doctor confidence and competence to prescribe end-of-life care medi	5
Risk factors for linezolid-induced thrombocytopenia in adult inpatients	5
Medicines-related interventions to support safe transitions for care home residents post hospital discharge: Do hospital-delivered interventions have a role?	5
Development and retrospective evaluation of a clinical decision support system for the efficient detection of drug-related problems by clinical pharmacists	5
European Society of Clinical Pharmacy definition of the term clinical pharmacy and its relationship to pharmaceutical care: a position paper	5
Commentary: how person-centred is pharmaceutical care?	5
Evaluating biosimilars: safety, efficacy, and regulatory considerations in clinical studies	5
Opioid, sedative, preadmission medication and iatrogenic withdrawal risk in UK adult critically ill patients: a point prevalence study	5
Association of polypharmacy with clinical outcomes and healthcare utilization in older adults with cardiometabolic diseases: a retrospective cohort study	5
The clinical and economic evidence of the management of urinary tract infections by community pharmacists in women aged 16 to 65 years: a systematic review	5
Effect of duloxetine on pain and opioid consumption after total knee and hip arthroplasty: a systematic review and meta-analysis of randomized controlled trials	5
Group based trajectory modeling to assess adherence to oral anticoagulants among atrial fibrillation patients with comorbidities: a retrospective study	5
Association of silodosin, tamsulosin, and naftopidil with delirium: analysis of the pharmacovigilance database in Japan	5
Community pharmacists' perceptions of their challenges in relation to older adults prescribed psychotropic medications: a focus-group study	5
Application of behavioural theories, models, and frameworks in pharmacy practice research based on published evidence: a scoping review	5
Developing a theory-based behavior change intervention to improve the prescription of surgical prophylaxis	5
Data mining and analysis for emicizumab adverse event signals based on the Food and Drug Administration Adverse Event Reporting System database	5
A cohort study of guselkumab in the treatment of psoriasis refractory to previous biologic therapies: effectiveness, safety and adherence	5
Exploring the impact of baseline platelet count on linezolid-induced thrombocytopenia: a retrospective single-center observation study	5
Credentialed pharmacist-led home medicines reviews targeting treatable traits and their impact on health outcomes in people with chronic obstructive pulmonary disease: a pre- and post-intervention stu	5